McKesson to acquire an 80% stake in PRISM Vision from Quad-C for $850m.

McKesson, a diversified healthcare services provider, agreed to acquire an 80% stake in PRISM Vision, a provider of general ophthalmology and retina management services, from Quad-C, a private equity firm, for $850m. “The acquisition of PRISM Vision will allow McKesson to build on our leadership in community practice and specialty solutions, while building a platform to serve the high-growth area of retina and ophthalmology. PRISM Vision has a strong track record and value proposition for community-based physicians and a strong leadership team focused on delivering superior retinal care, enhancing the provider experience and delivering innovative clinical research capabilities,” Brian Tyler, McKesson CEO.